LDR | |
01363nam a2200325 4500 |
001 |
|
007395399 |
003 |
|
MiAaHDL |
005 |
|
20111213000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
810109s1972 dcu f000 0 eng d |
035 |
⊔ |
⊔ |
‡asdr-umn000066249
|
035 |
⊔ |
⊔ |
‡a(OCoLC)34227170
|
035 |
⊔ |
⊔ |
‡a(MnU-B)79249
|
035 |
⊔ |
⊔ |
‡a(MnU-B)MNUM79249-B
|
035 |
⊔ |
⊔ |
‡a(MnU)notisABK9590
|
040 |
⊔ |
⊔ |
‡aMNU-B
‡cMNU-B
|
086 |
0 |
⊔ |
‡aHE 20.3702:G 28
|
245 |
0 |
4 |
‡aThe Prospects of gene therapy.
‡cEditor: Ernst Freese.
|
260 |
⊔ |
⊔ |
‡aWashington, D.C.,
‡bU. S. Govt. Print. Off.
‡c[1972]
|
300 |
⊔ |
⊔ |
‡a22 p.
‡c23 cm.
|
490 |
⊔ |
0 |
‡aDHEW publication;
‡vno. (NIH) 72-61
|
490 |
0 |
⊔ |
‡aFogarty International Center Conference report
|
500 |
⊔ |
⊔ |
‡aConference held May 24-26, 1971; sponsored by the National Institute of Neurological Diseases and Stroke and the John E. Fogarty International Center for Advanced Study in the Health Sciences.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
2 |
‡aGene Therapy.
|
650 |
⊔ |
2 |
‡aGenetic Diseases, Inborn
‡xprevention & control.
|
650 |
⊔ |
2 |
‡aGenetic Engineering.
|
650 |
⊔ |
2 |
‡aGenetics, Medical.
|
650 |
⊔ |
0 |
‡aMedical genetics.
|
700 |
1 |
⊔ |
‡aFreese, Ernst,
‡eed.
|
710 |
2 |
⊔ |
‡aJohn E. Fogarty International Center for Advanced Study in the Health Sciences.
|
710 |
2 |
⊔ |
‡aNational Institute of Neurological Diseases and Stroke.
|
CID |
⊔ |
⊔ |
‡a007395399
|
DAT |
0 |
⊔ |
‡a20100105094615.0
‡b20111213000000.0
|
DAT |
1 |
⊔ |
‡a20120815122756.0
‡b2025-01-04T19:11:50Z
|
CAT |
⊔ |
⊔ |
‡aSDR-UMN
‡dUNKNOWN
‡lloader.pl-001-001
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-umn000066249
‡aumn
‡bSDR
‡cUMN
‡pumn.31951000145058q
‡sUMN
‡1000066249
|
974 |
⊔ |
⊔ |
‡bUMN
‡cUMN
‡d20250104
‡sgoogle
‡uumn.31951000145058q
‡y1972
‡rpd
‡qbib
‡tUS fed doc
|